Pursuant to section 52(1) of the New Zealand Public Health and Disability Act 2000 and section 28(1)(a) and clause 1(1) of Schedule 5 to the Crown Entities Act 2004 (“CE Act”), and notice given under section 28(2) of the CE Act, I have appointed

Steve Maharey, cnzm

as a member and Chair of the Board of the Pharmaceutical Management Agency, for a term of office commencing on 1 August 2018 and ending on 31 July 2021.

Dated at Wellington this 1st day of August 2018.

Hon Dr DAVID CLARK, Minister of Health.